Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more
PEN is expected to report earnings to rise 41.46% to $1.16 per share on August 04
Q2'26
Est.
$1.16
Q1'26
Missed
by $0.25
Q4'25
Beat
by $0.08
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.03
The last earnings report on May 06 showed earnings per share of 81 cents, missing the estimate of $1.07. With 379.20K shares outstanding, the current market capitalization sits at 12.54B.